Bristol myers squibb(wallingford ct) 02 09 2018l

-

Bristol-Myers Squibb 5 Research Parkway, Wallingford, CT 06492

February 9, 2018 VIA FEDERAL EXPRESS

Susan Fracasso Rapid Response Coordinator Connecticut Department of Labor Rapid Response Unit 200 Folly Brook Blvd.

Wethersfield, CT 06109 William W. Dickinson, Jr., Mayor Mayor's Office 45 South Main Street, Room #310 Wallingford, CT 06492 RE:

Supplemental Notice Pursuant to Worker Adjustment and Retraining Notification Act

Dear Coordinator Fracasso and Mayor Dickinson: This letter is being issued to supplement our previous letter(s) dated January 31, 2017, and in accordance with any possible obligation under the federal Worker Adjustment and Retraining Notification Act, regarding Bristol-Myers Squibb's (the "Company") ongoing plan to close our Wallingford, CT site located at 5 Research Parkway, Wallingford, CT 06492 (the "Facility") by the end of 2018.

We write to advise that, in addition to the employee separations at the Facility previously described in our prior letters, the Company also now anticipates that 3 employees at the Facility will be separated effective February 6, 2018, 7 employees at the Facility will be separated effective March 31, 2018 and 97 employees separated effective April 3, 2018. The Wallingford Facility closure and any employee separations resulting therefrom are expected to be permanent. The Company's employees at the Wallingford Facility are not represented by a union or any other collective bargaining representative. All affected employees have been or will be notified of their employment terminations at least 60 days before their terminations are scheduled to occur.

Because the Company does not recognize bumping rights for its employees, terminated employees are not permitted to displace remaining employees based on seniority or any other factor.

An updated list of the job titles of the 107 employees separated or anticipated to be separated at the Wallingford Facility is attached hereto. Affected employees will be paid all wages and other benefits to which they are entitled through their date of termination. On or before the effective date of any affected employee's termination, the Company will provide information concerning benefits available under separate cover to eligible affected employees.

Affected employees will be paid all wages and other benefits to which they are entitled through their date of termination. On or before the effective date of each employee's termination, the Company will provide information concerning benefits available under separate cover to eligible affected employees.

This supplement is given based upon the best information available to the Company at this time.

For further information regarding this matter, please contact Tracy L. Smith at 203-677-3628.

Sincerely,

Tracy L. Smith Human Resources Site Head, Wallingford

Enclosure

RECEIVED DEPT, OF J,1,,.\!);BOl~ !i'.;'iD r1-':'t.11--1

1.J':!

¡Yi r. ~ e..U le}

LIST OF AFFECTED JOB POSITIONS AND NUMBER OF AFFECTED EMPLOYEES IN EACH POSITION Employees to be separated effective February 13, 2017: JOB TITLE ASSOC DIR CCO PROTOCOL MGMT

NUMBER OF AFFECTED EMPLOYEES 1

ASSOCIATE DIRECTOR PLANNING & EXECUTION

1

ASSOCIATE DIRECTOR, PROTOCOL MANAGEMENT

1

ASSOCIATE DIRECTOR PRODUCTIVITY MGMT

1

CLINICAL TRIAL ASSOCIATE, SUPERVISOR

1

CLINICAL TRIALS ASSOCIATE

4

PROJECT COORDINATOR

2

SENIOR OPERATIONS LEAD

1

Employees to be separated effective March 24, 2017:

JOB TITLE ASSOC DIRECTOR CLIN SYSTEMS

NUMBER OF AFFECTED EMPLOYEES 1

LEARNING MANAGER

1

LEARNING SPECIALIST

1

ASSOCIATE LEARNING SPECIALIST

1

VETERINARY SCIENCES TECHNICIAN

1

ASSISTANT VETERINARY SCIENTIST II

1

ASSOCIATE VETERINARY SCIENTIST I

1

OPERATIONS/TECHNICAL MANAGER II

1

DIRECTOR SENIOR PROJECT COORDINATOR OUTSOURCING MANAGEMENT COORDINATOR

1 .1 1

Employees to be separated effective March 25, 2017:

JOB TITLE MECHANICAL ENGINEER

NUMBER OF AFFECTED EMPLOYEES 1

PORTFOLIO MANAGER, BUSINESS PLANNING and MANAGEMENT SR. AUTOMATION ENGINEER

1

DIRECTOR IT

1

BIOLOGY CAPABILITY MANAGER

1

BUSINESS CAPABILITY MGR ASSOC DIRECT

1

1

LIST OF AFFECTED JOB POSITIONS AND NUMBER OF AFFECTED EMPLOYEES IN EACH POSITION

Employees to be separated effective April 3, 2017:

JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

1

*Executive Director Employees to be separated effective May 29, 2017:

JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

Assistant Veterinary Science Technician

1

Associate Veterinary Scientist I

3

Director

1

Group Director

1

Principal Scientist

2

Research. Scientist

2

Senior Principal Scientist

1

Senior Research Scientist

4

SeniorTechnician

2

Coordinator

1

Veterinary Sciences Technician

4

Veterinary Scientist

1

Employees to be separated effective June 2, 2017:

JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

Executive Director

1

Director

3

Employees to be separated effective July 10, 2017:

JOB TITLE Clinical Trial Plannino and Execution Lead, Oncoloav

NUMBER OF AFFECTED EMPLOYEES

Executive Director

1 1

Research Scientist

1

Senior Information Scientist

1

Schedule Manaoer

1

Employees to be separated effective August 14, 2017:

JOB TITLE Associate Director

NUMBER OF AFFECTED EMPLOYEES

Head, Compliance Leads

2 1

TA Lead

1

Associate Manager

1

LIST OF AFFECTED JOB POSITIONS AND NUMBER OF AFFECTED EMPLOYEES IN EACH POSITION Employees to be separated effective September 18, 2017:

NUMBER OF AFFECTED EMPLOYEES

JOB TITLE Research Scientist

7

Senior Research Investigator

1 1

Transformation Change Management Lead

Employees to be separated effective November 13, 2017:

JOB TITLE SENIOR RESEARCH INVESTIGATOR II

NUMBER OF AFFECTED EMPLOYEES

.

3

RESEARCH SCIENTIST II

2

EDT LEAD

1

REGULATORY STRATEGIST

1

PROJECT MANAGER

1

Employees to be separated effective December 19, 2017:

JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

RESEARCH SCIENTIST

5

ADMINISTRATIVE ASSISTANT

2

BUSINESS OPERATIONS LEAD

1

SENIOR VETERINARY SCIENCE TECHNICIANS

2

OPERATIONS MANAGERS

3

GROUP DIRECTOR

2

CLINICAL TRIAL LEAD

1

HEAD OF R&D LEARNING

1

DRUG PLANNING COORDINATORS

2

DRUG SUPPLY MANAGER

2

RANDOMIZATION SPECIALIST

2·

SENIOR DRUG PLANNING SPECIALIST

1

SHIPMENT EXECUTION TEAM LEAD

1

Employees to be separated effective January 9, 2018:

JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

Principal Analyst

3

Group Leader

1

Employees to be separated effective February 6, 2018:

JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

Operations Associate Liaison

1

Principal Scientist

1

Senior Compliance Auditor

1

Employees to be separated effective March 31, 2018:

JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

Terminology Administrator

1

Senior Project Coordinator

1

Associate Director, COIT

1

Terminology Specialist

3

Senior Enrollment Specialist

1

Employees to be separated effective April 3, 2018: JOB TITLE

NUMBER OF AFFECTED EMPLOYEES

Clinical Associate Directors

13

Clinical Managers

53

Clinical Leads

10

Operations Liaison

4

Project Coordinators

8

Database Developer

3

Protocol Specialist

2

Central Monitors

4

*Employee was scheduled to separate June 2, 2017. After receipt of 60-day advance notice, employee requested that BMS accelerate their Termination Date to April 3, 2017.